相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs
Regina Jitschin et al.
BLOOD (2014)
Mechanisms of action of tasquinimod on the tumour microenvironment
E. Raymond et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantation
Brenda De Keersmaecker et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Treatment with lenalidomide induces immunoactivating and counter-regulatory immunosuppressive changes in myeloma patients
A. Busch et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Sunitinib objective response in metastatic renal cell carcinoma: Analysis of 1059 patients treated on clinical trials
A. M. Molina et al.
EUROPEAN JOURNAL OF CANCER (2014)
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis
Thomas Condamine et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice
Hong Qin et al.
NATURE MEDICINE (2014)
Treatment of Tumors with Vitamin E Suppresses Myeloid Derived Suppressor Cells and Enhances CD8+T Cell-Mediated Antitumor Effects
Tae Heung Kang et al.
PLOS ONE (2014)
Immunological Dysregulation in Multiple Myeloma Microenvironment
Alessandra Romano et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
Kimberly A. Noonan et al.
CANCER IMMUNOLOGY RESEARCH (2014)
Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma
P. Leif Bergsagel et al.
BLOOD (2013)
Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans
Guellue Topal Goerguen et al.
BLOOD (2013)
Myeloid-Derived Suppressor Cells Function as Novel Osteoclast Progenitors Enhancing Bone Loss in Breast Cancer
Anandi Sawant et al.
CANCER RESEARCH (2013)
Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events
Elio Schouppe et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Modulation of CD8+ T-cell activation events by monocytic and granulocytic myeloid-derived suppressor cells
Elio Schouppe et al.
IMMUNOBIOLOGY (2013)
CD40 ligation reverses T cell tolerance in acute myeloid leukemia
Long Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients
David Vasquez-Dunddel et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
Linda Wang et al.
JOURNAL OF IMMUNOLOGY (2013)
Adiponectin Deficiency Suppresses Lymphoma Growth in Mice by Modulating NK Cells, CD8 T Cells, and Myeloid-Derived Suppressor Cells
Sora Han et al.
JOURNAL OF IMMUNOLOGY (2013)
Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
Indu R. Ramachandran et al.
JOURNAL OF IMMUNOLOGY (2013)
Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation
D. Mougiakakos et al.
LEUKEMIA (2013)
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial
M. Wang et al.
LEUKEMIA (2013)
Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer
Je-In Youn et al.
NATURE IMMUNOLOGY (2013)
Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
Lisa Christiansson et al.
PLOS ONE (2013)
Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
Bin Zhang et al.
PLOS ONE (2013)
Preclinical Evaluation of Invariant Natural Killer T Cells in the 5T33 Multiple Myeloma Model
Haneen Nur et al.
PLOS ONE (2013)
Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma
A. A. Chanan-Khan et al.
BLOOD CANCER JOURNAL (2013)
Myeloid derived suppressor cells - a new therapeutic target in the treatment of cancer
Robert Wesolowski et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2013)
Immune Regulatory Activity of Vitamin D3 in Head and Neck Cancer
M. Young et al.
Cancers (2013)
History of myeloid-derived suppressor cells
James E. Talmadge et al.
NATURE REVIEWS CANCER (2013)
Pomalidomide and its clinical potential for relapsed or refractory multiple myeloma: an update for the hematologist
Arleigh R. McCurdy et al.
THERAPEUTIC ADVANCES IN HEMATOLOGY (2013)
Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages
Ruder Novak et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Cucurbitacin B Regulates Immature Myeloid Cell Differentiation and Enhances Antitumor Immunity in Patients with Lung Cancer
Ping Lu et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2012)
Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Aparna Rao et al.
CANCER RESEARCH (2012)
Targeting Multiple-Myeloma-Induced Immune Dysfunction to Improve Immunotherapy Outcomes
Sergio Rutella et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells
Ariane Luyckx et al.
CLINICAL IMMUNOLOGY (2012)
Tumor-Infiltrating Monocytic Myeloid-Derived Suppressor Cells Mediate CCR5-Dependent Recruitment of Regulatory T Cells Favoring Tumor Growth
Eva Schlecker et al.
JOURNAL OF IMMUNOLOGY (2012)
Anti-Gr-1 antibody depletion fails to eliminate hepatic myeloid-derived suppressor cells in tumor-bearing mice
Chi Ma et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma
Giuseppina Bonanno et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
E. Van Valckenborgh et al.
LEUKEMIA (2012)
S100A9 Interaction with TLR4 Promotes Tumor Growth
Eva Kallberg et al.
PLOS ONE (2012)
Osteoclasts in Multiple Myeloma Are Derived from Gr-1+CD11b+Myeloid-Derived Suppressor Cells
Junling Zhuang et al.
PLOS ONE (2012)
The application and biology of immunomodulatory drugs (IMiDs) in cancer
Beiqing Pan et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Instruction of myeloid cells by the tumor microenvironment Open questions on the dynamics and plasticity of different tumor-associated myeloid cell populations
Elio Schouppe et al.
ONCOIMMUNOLOGY (2012)
Immunosuppressive CD14+HLA-DRlow/- monocytes in B-cell non-Hodgkin lymphoma
Yi Lin et al.
BLOOD (2011)
Proteomic analysis identifies galectin-1 as a predictive biomarker for relapsed/refractory disease in classical Hodgkin lymphoma
Peter Kamper et al.
BLOOD (2011)
Myeloid-derived suppressor cells - their role in haemato-oncological malignancies and other cancers and possible implications for therapy
Tamar Tadmor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells
Zhipeng Han et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model
Mengde Cao et al.
LABORATORY INVESTIGATION (2011)
Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13
Steven L. Highfill et al.
BLOOD (2010)
COX-2 inhibition improves immunotherapy and is associated with decreased numbers of myeloid-derived suppressor cells in mesothelioma. Celecoxib influences MDSC function
Joris D. Veltman et al.
BMC CANCER (2010)
5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
Julie Vincent et al.
CANCER RESEARCH (2010)
Anti-inflammatory Triterpenoid Blocks Immune Suppressive Function of MDSCs and Improves Immune Response in Cancer
Srinivas Nagaraj et al.
CLINICAL CANCER RESEARCH (2010)
IL-17 Promotes Tumor Development through the Induction of Tumor Promoting Microenvironments at Tumor Sites and Myeloid-Derived Suppressor Cells
Donggou He et al.
JOURNAL OF IMMUNOLOGY (2010)
Tim-3/Galectin-9 Pathway: Regulation of Th1 Immunity through Promotion of CD11b+Ly-6G+ Myeloid Cells
Valerie Dardalhon et al.
JOURNAL OF IMMUNOLOGY (2010)
Characterization of Cytokine-Induced Myeloid-Derived Suppressor Cells from Normal Human Peripheral Blood Mononuclear Cells
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2010)
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Srinivas Nagaraj et al.
JOURNAL OF IMMUNOLOGY (2010)
Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma
Christian Steidl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Increased Level of both CD4+FOXP3+ Regulatory T Cells and CD14+HLA-DR-/low Myeloid-Derived Suppressor Cells and Decreased Level of Dendritic Cells in Patients with Multiple Myeloma
M. K. Brimnes et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2010)
Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
Yuhuan Zheng et al.
BLOOD (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells
Eliana Ribechini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Increase in frequency of myeloid-derived suppressor cells in mice with spontaneous pancreatic carcinoma
Fei Zhao et al.
IMMUNOLOGY (2009)
Mechanism Regulating Reactive Oxygen Species in Tumor-Induced Myeloid-Derived Suppressor Cells
Cesar A. Corzo et al.
JOURNAL OF IMMUNOLOGY (2009)
Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
Per Bjork et al.
PLOS BIOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity
Kiavash Movahedi et al.
BLOOD (2008)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
Olga Turovskaya et al.
CARCINOGENESIS (2008)
Multiple myeloma - an update on diagnosis and treatment
Jo Caers et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives
Paulo C. Rodriguez et al.
IMMUNOLOGICAL REVIEWS (2008)
Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein
Pingyan Cheng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantation
P. Raanani et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2008)
Immunodeficiency and immunotherapy in multiple myeloma
Guy Pratt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function
Paolo Serafini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Peroxisome proliferator-activated receptor γ (PPAR-γ) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer
Jo A. Van Ginderachter et al.
BLOOD (2006)
In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma
Marc Beyer et al.
BLOOD (2006)
Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma
MK Brimnes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host
B Huang et al.
CANCER RESEARCH (2006)
Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2005)
High Th1/Th2 ratio in patients with multiple myeloma
H Ogawara et al.
LEUKEMIA RESEARCH (2005)
Myeloma cells (5TMM) and their interactions with the marrow marrow environment
E Menu et al.
BLOOD CELLS MOLECULES AND DISEASES (2004)
Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses
T Ghansah et al.
JOURNAL OF IMMUNOLOGY (2004)
A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma
MV Dhodapkar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Nitric oxide-independent CTL suppression during tumor progression: Association with arginase-producing (M2) myeloid cells
YQ Liu et al.
JOURNAL OF IMMUNOLOGY (2003)
Loss of S100A9 (MRP14) results in reduced interleukin-8-induced CD11b surface expression, a polarized microfilament system, and diminished responsiveness to chemoattractants in vitro
MP Manitz et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase
G Frumento et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6
M Ratta et al.
BLOOD (2002)
分享论文
